Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.080 | Biomarker | disease | BEFREE | YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma. | 31557131 | 2019 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | Recent studies showed that YAP is expressed in pancreas tissues in pancreatic ductal adenocarcinoma (PDAC) patients and experimental models of PDAC, with YAP largely found in cancer cells and pancreatic stellate cells (PaSC) in the stroma. | 31849712 | 2019 | ||||
|
0.080 | Biomarker | disease | BEFREE | LncRNA THAP9-AS1 promotes pancreatic ductal adenocarcinoma growth and leads to a poor clinical outcome via sponging miR-484 and interacting with YAP. | 31831555 | 2019 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | We and others find that YAP is up-regulated in pancreatic ductal adenocarcinoma (PDAC) and associated with worse prognosis of patients. | 29587800 | 2018 | ||||
|
0.080 | Biomarker | disease | BEFREE | Depletion of yes-associated protein 1 inhibited the invasion of pancreatic ductal adenocarcinoma cells via downregulation of Vimentin, matrix metalloproteinase-2, and matrix metalloproteinase-13, and upregulation of E-cadherin. | 28475017 | 2017 | ||||
|
0.080 | Biomarker | disease | BEFREE | Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex. | 28002618 | 2017 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | In our study, YAP expression was identified by immunohistochemistry and quantitative Real-time PCR from 45 pairs of human pancreatic ductal adenocarcinoma (PDAC) tissues and their adjacent non-tumor samples. | 28099921 | 2017 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma. | 16596258 | 2006 |